GPC3 and hepatocellular carcinoma: For instance, CAR-Ms targeting Glypican-3 (GPC3) are adept at recognizing and eliminating hepatocellular carcinoma (HCC) cells due to their antigen-specific recognition domains on the cell surface (151).